🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thanks to UNC's @IGHID, which hosted Dr. Ben Smith with UNC Emergency Medicine, for an interview with Contagion/ MJH Life Sciences®. Dr. Smith discussed "emerging pathogens preparedness" for an upcoming article. Learn more about Dr. Smith's areas of focus: unc.live/4kyo4al

Although COVID-19 has receded quite a bit from the minds of many, it still remains a virus that can present serious morbidity and mortality. Here is a review of clinical treatment strategies by an intensivist when seeing patients with severe COVID-19. contagionlive.com/view/the-linge…

#Breaking The federal agency approved the company’s mRNA-1345 (mRESVIA) vaccine for people who are between the ages of 18-59. #IDtwitter #MedTwitter contagionlive.com/view/fda-expan…

Gonorrhea resistance is rising, ceftriaxone resistance hit 8.1% in China. Now, the FDA has accepted the NDA for zoliflodacin, a first-in-class oral antibiotic backed by GARDP & Innoviva. A major step in the AMR fight. Read more: contagionlive.com/view/fda-accep…

The antiviral, glecaprevir/pibrentasvir, is the first and only oral 8-week pangenotypic treatment approved for people with acute or chronic hepatitis C. #IDtwitter #MedTwitter contagionlive.com/view/fda-expan…

.Jatin M. Vyas, MD, PhD offers some insights into the economics of development, the biology of fungal species, and the difficulties behind creating new antifungal molecules. #IDtwitter #MedTwitter contagionlive.com/view/decipheri…

#HCV treatment w/ DAAs reduces the risk of stroke, CKD, major cardiac events, and neurocognitive disorders, according to a study led by Dr. Naveed from the BC CDC. This article was originally posted on our sister site, HCPLive contagionlive.com/view/successfu…

❗ICYMI: Recent U.S. FDA News & Updates -AbbVie gets green light for acute HCV treatment -Moderna’s RSV vaccine expands 18–59 years. -Innoviva gets NDA accepted for oral gonorrhea treatment -Merck’s Enflonsia approved to protect infants from RSV Catch up: contagionlive.com

In an early release of his letter for the Summer issue, Editor-in-Chief Dr. Jason Gallagher, discusses the recent changes to the CDC's ACIP, and where professional societies must step in and lead. #IDtwitter #MedTwitter contagionlive.com/view/professio…

Who's ready for #asmicrobe2025 in LA - June 19-23, 2025? Join me & other experts at the #CareerOpportunity Summit, a full-day workshop, Th, Jun 19, 8A - 2:45P PDT. From 12:30P - 2:40P I'll share experiences & insights in Academia, esp. #medicallaboratory Science & #PublicHealth!

In case you missed it: New data from PROVE, the largest global real-world study on Shionogi Inc. (U.S.)'s antibiotic for use in adults with certain Gram-negative bacterial infections. Learn more: bit.ly/3YICqMD #Sponsored

Period.

In our latest podcast, Dr. Tim Gauthier discusses all things pathogens and antibiotics. He talks with Dr. Rodney E. Rohde, PhD "Doc R" about opportunities presented for stewardship when it combines diagnostics and treatment duration.Bug Pharmacist 💊🧫 Tim Gauthier #IDtwitter #MedTwitter contagionlive.com/view/a-passion…

Dr. Magnus Paulsson from Lund University on his study that sputum cultures taken before antibiotics are far more likely to identify true respiratory pathogens and less likely to yield misleading opportunists. Better diagnostics = smarter stewardship. contagionlive.com/view/value-of-…

🎥Yesterday, we had the pleasure of interviewing Dr. Robert Bransfield for the second time! We dove into how infections such as zoonotic & vector-borne, environmental factors, etc, can impact mental health, fuel violent behavior, & contribute to global instability. Stay tuned!

The CDC has reversed layoffs and reinstated staff at its hepatitis and STI labs, restoring key functions for disease tracking and outbreak response. Uncertainty about future operations continues. #CDC #PublicHealth #Hepatitis #STI Read more: contagionlive.com/view/impact-of…

🧠🦠 In Part 3, Dr. Robert Bransfield discussed psychiatric symptoms emerging years after infections like Lyme and other tick-borne diseases. Discover how these hidden links challenge traditional mental health treatment. Watch the full interview: contagionlive.com/view/psychiatr…

💉 30% of Americans express vaccine skepticism amid a measles outbreak—many citing autism concerns, per a new survey. How should ID clinicians respond to growing mistrust? 👇 Share your strategies for addressing vaccine hesitancy. Full read: contagionlive.com/view/30-of-ame…

🦠 ICYMI: MAD-ID 2025 Highlights Fidaxomicin’s Role in Reducing C difficile Recurrence MAD-ID The Antimicrobial Stewardship Meeting®️ Multiple studies underscored fidaxomicin's effectiveness in reducing C difficile recurrence, particularly among high-risk populations. contagionlive.com/view/mad-id-20…

❗BREAKING: U.S. FDA approved Gilead Sciences Yeztugo (lenacapavir) for HIV-1 PrEP, the first twice-yearly injectable option. The approval is based on the PURPOSE trials showing ≥99.9% prevention efficacy. Our interview with Dr. Jared Baeten: from Gilead contagionlive.com/view/fda-appro…